Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Axelsson

Showing results (41-50 of 80) with videos related to

Pageof 8
Sort By:
Neurobiology of Aging|June 16, 2021
Sex differences in dopamine integrity and brain structure among healthy older adults: Relationships to episodic memoryNina Karalija, Goran Papenberg, Anders Wåhlin, et al.
Nuclear Medicine Communications|March 2, 2023
Reliability and validity of visual analysis of [ 18 F]FE-PE2I PET/CT in early Parkinsonian diseaseSara Af Bjerkén, Jan Axelsson, Anne Larsson, et al.
Neuroscience Letters|December 27, 2021
N-acetylcysteine decreases dopamine transporter availability in the non-lesioned striatum of the 6-OHDA hemiparkinsonian ratAna Virel, Jarkko Johansson, Jan Axelsson, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2021
Dissociations between glucose metabolism and blood oxygenation in the human default mode network revealed by simultaneous PET-fMRILars Jonasson Stiernman, Filip Grill, Andreas Hahn, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 13, 2023
Striatal dopamine transporter and receptor availability correlate with relative cerebral blood flow measured with [<sup>11</sup>C]PE2I, [<sup>18</sup>F]FE-PE2I and [<sup>11</sup>C]raclopride PET in healthy individualsMy Jonasson, Andreas Frick, Patrik Fazio, et al.
Acta Oncologica (Stockholm, Sweden)|April 2, 2020
Body composition measured by computed tomography is associated with colorectal cancer survival, also in early-stage diseaseMona Shirdel, Fredrick Andersson, Robin Myte, et al.
Medical Physics|June 5, 2018
Technical Note: Adapting a GE SIGNA PET/MR scanner for radiotherapyPatrik Brynolfsson, Jan Axelsson, August Holmberg, et al.
Nuclear Medicine Communications|December 15, 2021
VNTR polymorphism in the SLC6A3 gene does not influence dopamine transporter availability measured by [18F]FE-PE2I PET or [123I]FP-Cit SPECTSusanna Jakobson Mo, Jan Axelsson, Lars J Stiernman, et al.
EJNMMI Physics|January 12, 2019
Radiation dosimetry of [<sup>68</sup>Ga]PSMA-11 in low-risk prostate cancer patientsKristina Sandgren, Lennart Johansson, Jan Axelsson, et al.
Fluids and Barriers of the CNS|July 2, 2025
qDESH: a method to quantify disproportionately enlarged subarachnoid space hydrocephalusSofia Behndig, Afroditi Lalou, Jan Axelsson, et al.
Pageof 8

Showing results (41-50 of 80) with videos related to

Sort By:
Pageof 8
Neurobiology of Aging|June 16, 2021
Sex differences in dopamine integrity and brain structure among healthy older adults: Relationships to episodic memoryNina Karalija, Goran Papenberg, Anders Wåhlin, et al.
Nuclear Medicine Communications|March 2, 2023
Reliability and validity of visual analysis of [ 18 F]FE-PE2I PET/CT in early Parkinsonian diseaseSara Af Bjerkén, Jan Axelsson, Anne Larsson, et al.
Neuroscience Letters|December 27, 2021
N-acetylcysteine decreases dopamine transporter availability in the non-lesioned striatum of the 6-OHDA hemiparkinsonian ratAna Virel, Jarkko Johansson, Jan Axelsson, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 2021
Dissociations between glucose metabolism and blood oxygenation in the human default mode network revealed by simultaneous PET-fMRILars Jonasson Stiernman, Filip Grill, Andreas Hahn, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 13, 2023
Striatal dopamine transporter and receptor availability correlate with relative cerebral blood flow measured with [<sup>11</sup>C]PE2I, [<sup>18</sup>F]FE-PE2I and [<sup>11</sup>C]raclopride PET in healthy individualsMy Jonasson, Andreas Frick, Patrik Fazio, et al.
Acta Oncologica (Stockholm, Sweden)|April 2, 2020
Body composition measured by computed tomography is associated with colorectal cancer survival, also in early-stage diseaseMona Shirdel, Fredrick Andersson, Robin Myte, et al.
Medical Physics|June 5, 2018
Technical Note: Adapting a GE SIGNA PET/MR scanner for radiotherapyPatrik Brynolfsson, Jan Axelsson, August Holmberg, et al.
Nuclear Medicine Communications|December 15, 2021
VNTR polymorphism in the SLC6A3 gene does not influence dopamine transporter availability measured by [18F]FE-PE2I PET or [123I]FP-Cit SPECTSusanna Jakobson Mo, Jan Axelsson, Lars J Stiernman, et al.
EJNMMI Physics|January 12, 2019
Radiation dosimetry of [<sup>68</sup>Ga]PSMA-11 in low-risk prostate cancer patientsKristina Sandgren, Lennart Johansson, Jan Axelsson, et al.
Fluids and Barriers of the CNS|July 2, 2025
qDESH: a method to quantify disproportionately enlarged subarachnoid space hydrocephalusSofia Behndig, Afroditi Lalou, Jan Axelsson, et al.
Pageof 8